Status:
COMPLETED
HERA FIb Registry for Patients With Atrial Fibrillation
Lead Sponsor:
University Hospital Heidelberg
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The single-center HERA AFIb registry was created to assess real-world prevalence, demographic characteristics and management of patients with atrial fibrillation (AF) in the era of novel oral anticoag...
Detailed Description
HERA AFIb is a single-center retrospective registry which enrolled consecutive cases presenting with atrial fibrillation at the emergency department of University Hospital of Heidelberg. Clinical para...
Eligibility Criteria
Inclusion
- documented atrial fibrillation
- availability of at least one hsTnT measurement
Exclusion
- lost to follow-up
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
12297 Patients enrolled
Trial Details
Trial ID
NCT05995561
Start Date
June 1 2009
End Date
April 1 2020
Last Update
May 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Heidelberg
Heidelberg, Baden-Wurttemberg, Germany, 69120